Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 8 Breast Neoplasms 8 Neoplasm Metastasis 7 Lung Neoplasms 6 Rectal Neoplasms 5 Sarcoma 4 Prostatic Neoplasms 4 Melanoma 4 Colonic Neoplasms 4 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Thymoma 2 Neoplasms 2 Mouth Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma 2 Adenomatous Polyposis Coli 2 Uterine Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Thrombocytosis 1 Stomach Neoplasms 1 Recurrence 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Paranasal Sinus Neoplasms 1 Papilloma 1 Pain 1

Interventions

telapristone acetate 9 vilaprisan 6 ulipristal acetate 4 Sugars 2 Mifepristone 2 Bupivacaine 2 ulipristal 1 ferrous sulfate 1 epigallocatechin gallate 1 Vitamin B 6 1 Uterine Myomectomy 1 Tranexamic Acid 1 Tea 1 Standard of Care 1 Radiofrequency Ablation 1 Pregabalin 1 Morphine 1 Misoprostol 1 Lidocaine 1 Leuprolide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Leiomyoma × Celecoxib × Clear all

NCT01555073 2016-07-28

Preemptive Analgesia Following Uterine Artery Embolization

Northwestern University

Phase 4 Terminated

23 enrolled 6 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡